BioStem Technologies Secures Medicare Coverage for Nationwide Launch of Vendaje AC®

BioStem Technologies Inc. (OTC: BSEM) has expanded access to Vendaje AC®, a wound care product designed to support healing in chronic, non-healing wounds, across the United States through its partnership with Venture Medical. This broader rollout follows the October 1, 2024, Center for Medicare Services announcement, which established reimbursement for Vendaje AC® across all Medicare… [Read More]

BigBear.ai’s veriScan™ Brings Biometric Boarding to Denver International Airport

BigBear.ai (NYSE: BBAI) has successfully installed its biometric verification solution, veriScan™, at Denver International Airport (DEN). Now operational at 14 international departure gates, veriScan™ streamlines boarding for over 46,600 international passengers, helping airlines reduce boarding times and improve security. The process is voluntary for U.S. citizens, who may opt out if desired. Using U.S. Customs… [Read More]

Humacyte Presents Positive Phase 3 Results for ATEV™ in Hemodialysis Access

Humacyte, Inc. (Nasdaq: HUMA) has presented encouraging Phase 3 clinical results for its acellular tissue-engineered vessel (ATEV™) in hemodialysis access, demonstrating superior efficacy over the current standard of care, autogenous fistula, at six and 12 months. The findings, shared at the American Society of Nephrology’s Kidney Week 2024, highlight ATEV’s enhanced performance, especially in patient… [Read More]

Onsemi Reports Soft Q4 Outlook Citing Near-Term Macro Hesitation. Investors Still Turned On as Shares Rise

Today ON Semiconductor Corporation (ON) reported Q3 financial results with EPS beating consensus of $0.99 vs FactSet $0.97 and revenue of $1.76Bn vs FactSet $1.75Bn. While the Q3 report came in line with expectations, its quarterly guidance underwhelmed as its sales have continued to slide amid macro challenges.  Q4 revenue guidance was $1.76Bn at the… [Read More]

Lightbridge Surges 28% as New Study Highlights Safety Gains Over Traditional Nuclear Fuel

Lightbridge Corporation (Nasdaq: LTBR) announced compelling new research at the TopFuel 2024 Conference, presenting independent MIT and SIA studies that showcase the safety and performance benefits of its advanced Lightbridge Fuel™ in nuclear reactors. Key Findings: MIT Study: Simulations within NuScale’s Small Modular Reactor reveal that Lightbridge Fuel operates at notably lower temperatures than conventional… [Read More]

MIRA Pharmaceuticals’ Ketamir-2 Outperforms FDA-Approved Gabapentin by 60% in Reducing Chemotherapy-Induced Pain

Shares of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) rose 14% following the announcement of new preclinical data showing that Ketamir-2, an innovative oral ketamine analog, demonstrated 60% greater efficacy than gabapentin, the current FDA-approved standard, in reducing chemotherapy-induced neuropathic pain. These findings will be presented at the Pain Therapeutics Summit in Boston. Key Highlights: In a… [Read More]

What You Need to Know: Earnings Update, Upcoming Mag 7 Reports and Market Themes

Earnings Update – Metrics Slip        In the latest FactSet Earnings Insight report, 37% of S&P 500 companies have announced earnings. 75% of those companies who have reported beat consensus EPS expectations, which is currently below the 78% one-year average and the five-year average of 77%. In aggregate, companies are reporting earnings that are 5.7% above… [Read More]

Biora Therapeutics Advances BioJet™ Oral Delivery Platform for Needle-Free Drug Delivery at PODD Conference

Biora Therapeutics, Inc. (Nasdaq: BIOR), a biotech company focused on transforming drug delivery, presented new advancements for its BioJet™ Oral Delivery Platform at the 14th Annual Partnership in Drug Delivery (PODD) meeting in Boston, Massachusetts. The BioJet technology is designed as a swallowable, needle-free autoinjector to replace traditional injections with oral delivery, aiming to increase… [Read More]

Stocks making the biggest moves premarket: Exxon, Spotify, Boeing, McDonald’s, TSMC and more

Here’s the quick rundown on the companies making waves in premarket trading. Spotify’s stock is humming along, up by 2%, following Wells Fargo’s endorsement of it as a top stock choice. Analyst Steven Cahall is especially enthusiastic about the company’s expanding profit margins, robust product offering, and evolving relationships with record labels. Robinhood earned an… [Read More]